Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Abroad (travel likely)RecruitingPHASE2, PHASE3
Conditions
Tuberculosis, Pulmonary · Tuberculosis, Multidrug-Resistant · Tuberculosis, MDR
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Center for Communicable Diseases, Ulaanbaatar, Mongolia
Contact: Study coordinator (Bazarrahchaa Tsogt)Institute of Chest Diseases, Kotri, Pakistan
Contact: Study coordinator (Uzma Khan)Hospital Nacional Sergio E. Bernales, Lima, Peru
Contact: Study coordinator (Leonid Lecca)Contact: Study coordinator (Olivia Peña)Policlínico SES, Lima, Peru
Contact: Study coordinator (Leonid Lecca)Contact: Study coordinator (Rosa Infante)Mulago National Referral Hospital, Kampala, Uganda
Contact: Study coordinator (William Worodria)Hanoi Lung Hospital, Hanoi, Vietnam
Contact: Study coordinator (Dinh Van Luong)Contact: Study coordinator (Nguyen Binh Hoa)
Study leads
Gustavo E Velásquez, MD, MPH
Principal Investigator
University of California, San Francisco